Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study

To see complete record on, please visit this link

Id: NCT05384678

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Recruiting

Start Date: November 15, 2022

Last Update: November 2, 2022

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: N,N-dimethyltryptamine (DMT) is a psychoactive substance with similar effects such as LSD or psilocybin. However, DMT is less well characterized than the latter substances. The present study is a modern randomized cross-over trial, investigating different continuous intravenous DMT dose rates over a broad dose range. Thus, different doses will be tested and related to subjective and autonomic effects.

  • Healthy

Total execution time in seconds: 0.49705600738525